Asset Dedication LLC’s Genmab GMAB Stock Holding History

Asset Dedication LLC’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-7	Closed	-$193	–	1234
2026 Q2	$193	Buy	+7	New	+$186	﹤0.01%	1208

Other funds holding GMAB

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Eagle Global Advisors Houston, Texas $3.02B AUM 27.86% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return

Asset Dedication LLC's GMAB Position: Q3 2026 in Review

Asset Dedication LLC sold out of Genmab (GMAB) in Q3 2026, closing a stake of 7 shares — an estimated $193 sold.

Asset Dedication LLC first reported a position in GMAB in Q2 2026 and held it in 1 quarter. The position peaked at $193 in Q2 2026. 137 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

Asset Dedication LLC reported no remaining Genmab position as of Q3 2026 after selling out during the quarter.
Asset Dedication LLC sold 7 Genmab shares in Q3 2026, an estimated $193.
Asset Dedication LLC first reported a position in Genmab in Q2 2026 and held it in 1 quarter.
Asset Dedication LLC's Genmab position peaked at $193 in Q2 2026.
137 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Asset Dedication LLC's 13F filing for Q3 2026, filed 3 Nov 2026.